The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
hTERT Is Expressed in Cancer Cell Lines Despite Promoter DNA Methylation by Preservation of Unmethylated DNA and Active Chromatin around the Transcription Start Site
Published version of a preprint
Abstract
hTERT, which encodes the catalytic subunit of telomerase and is expressed in most immortalized and cancer cells, has been reported to have increased DNA methylation in its promoter region in many cancers. This pattern is inconsistent with observations that DNA methylation of promoter CpG islands is typically associated with gene silencing. Here, we provide a comprehensive analysis of promoter DNA methylation, chromatin patterns, and expression of hTERT in cancer and immortalized cells. Methylation-specific PCR and bisulfite sequencing of the hTERT promoter in breast, lung, and colon cancer cells show that all cancer cell lines retain alleles with little or no methylation around the transcription start site despite being densely methylated in a region 600 bp upstream of the transcription start site. By real-time reverse transcription-PCR, all cancer cell lines express hTERT. Chromatin immunoprecipitation (ChIP) analysis reveals that both active (acetyl-H3K9 and dimethyl-H3K4) and inactive (trimethyl-H3K9 and trimethyl-H3K27) chromatin marks are present across the hTERT promoter. However, using a novel approach combining methylation analysis of ChIP DNA, we show that active chromatin marks are associated with unmethylated DNA, whereas inactive marks of chromatin are associated with methylated DNA in the region around the transcription start site. These results show that DNA methylation patterns of the hTERT promoter (−150 to +150 around the transcription start) are consistent with the usual dynamics of gene expression in that the absence of methylation in this region and the association with active chromatin marks allow for the continued expression of hTERT. [Cancer Res 2007;67(1):194–201]
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These data suggest that the absence of methylation and the association with active chromatin marks around the transcription start site allow for the expression of hTERT (Fig. 1), indicating that the DNA methylation pattern of the hTERT promoter is consistent with the usual dynamics of gene expression.”
From Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers (2008) · cites this paper as [62]
Citations
Cites
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,634
Self-citationRole of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing
Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H., Tempst, P., Jones, R. S., & Zhang, Y. (2002) · Science · doi:10.1126/science.1076997 · Cited by 3,775
Gene Silencing in Cancer in Association with Promoter Hypermethylation
Herman, J. G., & Baylin, S. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023075 · Cited by 3,471
Self-citationIdentification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400
The RNA Component of Human Telomerase
Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., et al. (1995) · Science · doi:10.1126/science.7544491 · Cited by 2,227
Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E. W., Burger, P. C., Baylin, S. B., & Sidransky, D. (1995) · Nature Medicine · doi:10.1038/nm0795-686 · Cited by 1,992
Self-citationIncidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma
Herman, J. G., Umar, A., Polyák, K., Graff, J. R., Ahuja, N., Issa, J. J., Markowitz, S. D., Willson, J. K. V., Hamilton, S. R., Kinzler, K. W., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6870 · Cited by 1,887
Self-citationMeyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L. W., Steiner, P., Caddle, S. D., Ziaugra, L., Beijersbergen, R. L., Davidoff, M. J., Liu, Q., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80538-3 · Cited by 1,784
Cited by
Sorted by citations
Items 101–200 of 210
Tost, J. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-43624-1_15 · Cited by 26
Telomerase regulation in hematological cancers: A matter of stemness?
Deville, L., Hillion, J., & Ségal-Bendirdjian, E. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.01.016 · Cited by 27
Hypermethylation of the DLC1 CpG island does not alter gene expression in canine lymphoma
Bryan, J. N., Jabbes, M., Berent, L. M., Arthur, G. L., Taylor, K. H., Rissetto, K., Henry, C. J., Rahmatpanah, F. B., Rankin, W. V., Villamil, J. A., et al. (2009) · BMC Genetics · doi:10.1186/1471-2156-10-73 · Cited by 26
TERT Promoter Hypermethylation in Gastrointestinal Cancer: A Potential Stool Biomarker
Liu, L., Liu, C., Fotouhi, O., Fan, Y., Wang, K., Xia, C., Shi, B., Zhang, G., Wang, K., Kong, F., et al. (2017) · The Oncologist · doi:10.1634/theoncologist.2017-0064 · Cited by 25
Avin, B. A., Wang, Y., Gilpatrick, T., Workman, R. E., Lee, I., Timp, W., Umbricht, C. B., & Zeiger, M. A. (2019) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22735 · Cited by 28
Chapter 2 Cellular and Molecular Biological Aspects of Cervical Intraepithelial Neoplasia
Kisseljov, F. L., Sakharova, O., & Kondratjeva, T. T. (2008) · International review of cytology · doi:10.1016/s1937-6448(08)01202-1 · Cited by 24
Oncolytic viruses: A new immunotherapeutic approach for breast cancer treatment?
Cejalvo, J. M., Falato, C., Villanueva, L., Tolosa, P., González, X., Pascal, M., Canes, J., Gavilá, J., Manso, L., Pascual, T., et al. (2022) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2022.102392 · Cited by 24
PRIMEGENS-v2: genome-wide primer design for analyzing DNA methylation patterns of CpG islands
Srivastava, G. P., Guo, J., Shi, H., & Xu, D. H. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn320 · Cited by 23
Sui, X., Kong, N., Wang, Z., & Pan, H. (2013) · Oncology Letters · doi:10.3892/ol.2013.1367 · Cited by 23
Pervasive promoter hypermethylation of silenced TERT alleles in human cancers
Esopi, D., Graham, M. K., Brosnan‐Cashman, J. A., Meyers, J. L., Vaghasia, A. M., Gupta, A. K., Kumar, B., Haffner, M. C., Heaphy, C. M., Marzo, A. M. D., et al. (2020) · Cellular Oncology · doi:10.1007/s13402-020-00531-7 · Cited by 23
The limiting factors of oncolytic virus immunotherapy and the approaches to overcome them
Hu, P.-Y., Fan, X., Zhang, Y.-N., Wang, S., Wan, W.-J., Pan, H., & Mou, X. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-10802-w · Cited by 22
Phipps, S. M. O., Love, W. K., White, T. J., Andrews, L. G., & Tollefsbol, T. O. (2009) · PubMed · Cited by 21
Cao, Y., Wang, B., Wang, D., Zhan, D., Mai, C., Wang, P., Wei, Q., Liu, Y., Wang, H., He, W., et al. (2019) · International Journal of Genomics · doi:10.1155/2019/7076513 · Cited by 21
Exploring hTERT promoter methylation in cutaneous T‐cell lymphomas
Chebly, A., Ropio, J., Péloponèse, J., Poglio, S., Prochazkova‐Carlotti, M., Cherrier, F., Ferrer, J., Idrissi, Y., Segal‐Bendirdjian, E., Chouery, É., et al. (2021) · Molecular Oncology · doi:10.1002/1878-0261.12946 · Cited by 20
Zhang, B., Ling, T., Zhaxi, P., Cao, Y. Q., Qian, L., Zhao, D., Kang, W., Zhang, W., Wang, L., Xu, G., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.03.029 · Cited by 19
Degerman, S., Landfors, M., Siwicki, J. K., Revie, J., Borssén, M., Evelönn, E., Forestier, E., Chrzańowska, K., Rydén, P., Keith, W. N., et al. (2014) · Neoplasia · doi:10.1016/j.neo.2014.07.001 · Cited by 18
High expression of APC is an unfavorable prognostic biomarker in T4 gastric cancer patients
Du, W., Lin, C., & Chen, W. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i31.4452 · Cited by 18
THOR is a targetable epigenetic biomarker with clinical implications in breast cancer
Apolónio, J. D., Dias, J. S., Fernandes, M. T., Komosa, M., Lipman, T., Zhang, C. H., Leao, R. R. N., Lee, D., Nunes, N. M., Maia, A.-T., et al. (2022) · Clinical Epigenetics · doi:10.1186/s13148-022-01396-3 · Cited by 19
Genetic and epigenetic trends in telomere research: a novel way in immunoepigenetics
Melicher, D., Buzás, E. I., & Falus, A. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1991-2 · Cited by 17
Tost, J. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-11454-0_16 · Cited by 15
Atri, S., Nasoohi, N., & Hodjat, M. (2020) · Current Molecular Pharmacology · doi:10.2174/1874467213666200512080122 · Cited by 15
Telomere Maintenance in Pediatric Cancer
Ackermann, S., & Fischer, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235836 · Cited by 15
Ferrocenylnaphthalene Diimide-Based Electrochemical Detection of Aberrant Methylation in hTERT Gene
Sato, S., Saeki, T., Tanaka, T., Kanezaki, Y., Hayakawa, M., Haraguchi, K., Kodama, M., Nishihara, T., Tominaga, K., & Takenaka, S. (2014) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-014-1030-z · Cited by 14
Li, S., Hu, G., Chen, Y., Sang, Y., Tang, Q., & Liu, R. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03459-2 · Cited by 15
Molano, M., Moreno‐Acosta, P., MORALES, N., Burgos, M., Buitrago, L., Gamboa, Ó., ALVAREZ, R., Garland, S. M., Tabrizi, S. N., Steenbergen, R. D. M., et al. (2016) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20011 · Cited by 13
Ravindranathan, A., Cimini, B. A., Diolaiti, M. E., & Stohr, B. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206525 · Cited by 13
hTERT methylation is necessary but not sufficient for telomerase activity in colorectal cells
Valls, C., Bougel, S., Piñol, C., Salas, J. V., & Benhattar, J. (2011) · Oncology Letters · doi:10.3892/ol.2011.386 · Cited by 12
Li, J., Zheng, P. C. J.-R., & Wang, Y.-Z. (2017) · World Journal of Surgical Oncology · doi:10.1186/s12957-017-1170-z · Cited by 12
Haraguchi, K., Yada, N., Sato, S., Habu, M., Hayakawa, M., Takahashi, O., Sasaguri, M., Takenaka, S., Yoshioka, I., Matsuo, K., et al. (2017) · Apmis · doi:10.1111/apm.12723 · Cited by 12
ALV Integration-Associated Hypomethylation at the TERT Promoter Locus
Lam, G., & BEEMON, K. L. (2018) · Viruses · doi:10.3390/v10020074 · Cited by 11
Healey, M. A., Deaton, S. L., Alder, J. K., Winnepenninckx, V. J. L., Casero, R. A., & Herman, J. G. (2010) · Epigenetics · doi:10.4161/epi.5.5.11929 · Cited by 12
Self-citationChatagnon, A., Ballestar, E., Esteller, M., & Dante, R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009665 · Cited by 11
DNA Methylation Analysis in Human Cancer
O’Sullivan, E., & Goggins, M. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-287-2_7 · Cited by 11
Nikkhoi, S. K., Dorostkar, R., Ranjbar, S., Heydarzadeh, H., Tat, M., Ghalavand, M., Farasat, A., & Hashemzadeh, M. S. (2016) · Iranian Journal of Biotechnology · doi:10.15171/ijb.1429 · Cited by 10
Fotouhi, O., Ghaderi, M., Wang, N., Zedenius, J., Kjellman, M., Xu, D., Juhlin, C. C., & Larsson, C. (2019) · Epigenetics · doi:10.1080/15592294.2019.1634987 · Cited by 10
Zhang, Z.-X., Wang, Y., Tao, Z., Chen, S., Xiao, B., & Zhou, T. (2014) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2013.1581 · Cited by 10
Li, Q., Zhai, Y., Man, X., Zhang, S., & An, X. (2020) · Cellular Reprogramming · doi:10.1089/cell.2019.0060 · Cited by 10
The Regulation of Telomerase in Oncogenesis
Skvortzov, D. A., Rubzova, M. P., Zvereva, M. I., Fl, K., & Donzova, O. A. (2009) · Acta Naturae · doi:10.32607/20758251-2009-1-1-51-67 · Cited by 12
Acute application of cisplatin affects methylation status in neuroblastoma cells
Tabata, K. (2011) · Oncology Reports · doi:10.3892/or.2011.1222 · Cited by 10
Epigenetic regulation of telomerase expression in HIV-1-specific CD8+ T cells
Williams, K. L., Seiss, K., Beamon, J., Pereyra, F., Rosenberg, E. S., Walker, B. D., Yu, X. G., & Lichterfeld, M. D. (2010) · AIDS · doi:10.1097/qad.0b013e32833c7170 · Cited by 9
Garsuault, D., Bouyer, C., Nguyen, É., Kandhari, R., Prochazkova‐Carlotti, M., Chevret, E., Forgez, P., & Ségal‐Bendirdjian, E. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12681 · Cited by 10
Epigenetic features in regulation of telomeres and telomerase in stem cells
Doğan, F., & Forsyth, N. R. (2021) · Emerging Topics in Life Sciences · doi:10.1042/etls20200344 · Cited by 8
Lee, S., Chang, T., Schreiner, P. A., Fan, Y., Agarwal, N., Owens, C. R., Dummer, R., Kirkwood, J. M., Barnhill, R. L., Theodorescu, D., et al. (2022) · Cancers · doi:10.3390/cancers14164018 · Cited by 8
Taylor, J. Y., Jones‐Patten, A., Prescott, L., Potts‐Thompson, S., Joyce, C., Tayo, B. O., & Saban, K. L. (2024) · PLoS ONE · doi:10.1371/journal.pone.0295293 · Cited by 7
TERT Promoter Methylation Is Oxygen-Sensitive and Regulates Telomerase Activity
Doğan, F., & Forsyth, N. R. (2024) · Biomolecules · doi:10.3390/biom14010131 · Cited by 7
Xu, H., Wang, W., Zhao, J., Li, T., & Kang, X. (2019) · Medicine · doi:10.1097/md.0000000000017578 · Cited by 7
Koukourikis, P., Papaioannou, M., Georgopoulos, P., Apostolidis, I., Pervana, S., & Apostolidis, A. (2023) · Biology · doi:10.3390/biology12081126 · Cited by 7
Guo, N., Cheng, D., Li, Z. H., Zhou, Q., Zhou, J., Lin, Q., Zeng, B., Liao, Q., & Chen, R. F. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24218 · Cited by 7
Transcriptional and epigenetic landscape of Ca2+-signaling genes in hepatocellular carcinoma
Hernández‐Oliveras, A., Izquierdo‐Torres, E., Hernández-Martínez, G., Zarain‐Herzberg, Á., & Santiago-Garcı́a, J. (2021) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-020-00597-w · Cited by 7
Mahdiannasser, M., Haghpanah, V., Damavandi, E., Kabuli, M., Tavangar, S. M., Larijani, B. A., & Ghadami, M. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05315-8 · Cited by 6
Telomerase inhibition alters telomere maintenance mechanisms in laryngeal squamous carcinoma cells
Chen, W., Chen, S. M., Yu, Y., Xiao, B. K., Huang, Z., & Tao, Z. (2010) · The Journal of Laryngology & Otology · doi:10.1017/s0022215109992854 · Cited by 6
Riley, L. B., & Anderson, D. W. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375709-8.00032-0 · Cited by 8
Masood, S., ElGabry, E. A., Zhang, C., & Wang, Z. (2016) · Diagnostic Cytopathology · doi:10.1002/dc.23505 · Cited by 6
Photoswitchable intein for light control of covalent protein binding and cleavage
Baloban, M., Manoilov, K. Y., Karasev, M. M., Verkhusha, V. V., & Shcherbakova, D. M. (2025) · Nature Communications · doi:10.1038/s41467-025-63595-9 · Cited by 5
Associations of meditation with telomere dynamics: a case–control study in healthy adults
Dasanayaka, N. N., Sirisena, N. D., & Samaranayake, N. (2023) · Frontiers in Psychology · doi:10.3389/fpsyg.2023.1222863 · Cited by 5
The TERT Promoter is Polycomb-Repressed in Neuroblastoma Cells with Long Telomeres
Graham, M. K., Xu, B., Davis, C., Meeker, A. K., Heaphy, C. M., Yegnasubramanian, S., Dyer, M. A., & Zeineldin, M. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-22-0287 · Cited by 6
Pan, X., Bowman, M. E., Scott, R. J., Fitter, J. T., Smith, R., & Zakár, T. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170671 · Cited by 5
Mizuguchi, M., Hara, T., Yoshita‐Takahashi, M., Kohda, T., Tanaka, Y., & Nakamura, M. (2021) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2021.100984 · Cited by 5
Oliva-Rico, D., Fabián-Morales, E., Cáceres-Gutiérrez, R. E., Gudiño, A., Cisneros-Soberanis, F., Domínguez, J., Almaraz-Rojas, O., Arriaga-Canon, C., Hernández, C. C., la Rosa, C. D., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063271 · Cited by 4
DNA methylation in germ cell tumour aetiology: current understanding and outstanding questions
Cusack, M., & Scotting, P. J. (2013) · Reproduction · doi:10.1530/rep-12-0382 · Cited by 4
Telomeres and Telomerase in Neuroblastoma
Hajj, J. E., Garsuault, D., Bouyer, C., Nguyen, É., Hilal, G., & Ségal-Bendirdjian, E. (2017) · InTech eBooks · doi:10.5772/intechopen.69567 · Cited by 4
Senchenko, V. N. (1994) · Oncology Reports · doi:10.3892/or_00000030 · Cited by 4
DNA Methylation of thehTERTGene in Breast Cancer Revisited: Diagnostic and Clinical Implications
Masood, S., ElGabry, E. A., Zhang, C., & Wang, Z. (2016) · Laboratory Medicine · doi:10.1093/labmed/lmw043 · Cited by 4
Nyembwe, A., Zhao, Y., Caceres, B. A., Belsky, D. W., Ryan, C. P., Taylor, B., Morrison, M. T., Prescott, L., Potts‐Thompson, S., Aziz, A., et al. (2025) · Epigenomes · doi:10.3390/epigenomes9020014 · Cited by 3
Variations in telomere maintenance and the role of telomerase inhibition in gastrointestinal cancer
Heeg, S. (2015) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s52808 · Cited by 3
Mauger, F., & Deleuze, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814259-2.00003-0 · Cited by 3
Epigenetic Disturbances in Colorectal Cancer
Sarah Derks, A., & van Engeland, M. (2013) · Springer eBooks · doi:10.1007/978-3-642-38404-2_12 · Cited by 2
Lawrence, T., & Murphy, T. M. (2018) · OBM Genetics · doi:10.21926/obm.genet.1804055 · Cited by 2
Mizuguchi, M., Takatori, M., Sakihama, S., Yoshita‐Takahashi, M., Imaizumi, N., Takahashi, Y., Hasegawa, H., Karube, K., Fukushima, T., Nakamura, M., et al. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-022-00475-0 · Cited by 2
Epigenetic Alterations in Pancreatic Cancer
Ayars, M., & Goggins, M. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6549-2_9 · Cited by 2
Construction and Function Study of Expression Vector of rVBMDMP Gene Regulated by hTERT Promotor*
Zhang, Z., Xiu-sheng, H., Luo, Z., Li, Y., & Cao, J. (2010) · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS · doi:10.3724/sp.j.1206.2009.00503 · Cited by 1
A Transnational Study of Vocational Guidance and Counselling Provision for Women Returners.
Clayton, P. (1996) · Adults learning · Cited by 1
Telomerase and Its Therapeutic Implications in Cancer
Kumar, R., Gupta, N., & Sharma, A. (2022) · Springer eBooks · doi:10.1007/978-981-16-4752-9_14 · Cited by 1
Promoter CpG island methylation in colorectal cancer:
Sarah Derks, A., & van Engeland, M. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511777271.028 · Cited by 1
Ibrahim, K. G., Chivandi, E., Erlwanger, K. H., & Brooksbank, R. L. (2019) · Journal of Biological Sciences · doi:10.3923/jbs.2019.224.230 · Cited by 1
Telomerase Control by Epigenetic Processes in Cellular Senescence
Chen, H., & Tollefsbol, T. O. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0639-7_11 · Cited by 1
DNA Hypermethylation and Oncogenesis
Berletch, J. B., Tollefsbol, T. O., Andrews, L., & DeAngelis, J. T. (2008) · CRC Press eBooks · doi:10.1201/9781420045802.ch3 · Cited by 1
Oxygen-sensitive TERT Promoter Methylation Regulates Telomerase ActivityPreprint
Forsyth, N. R., & Doğan, F. (2022) · Preprints.org · doi:10.20944/preprints202211.0074.v1 · Cited by 1
Transcriptional Regulation of Human Telomerase
Farsetti, A., & Cong, Y. (2012) · Wiley eBooks · doi:10.1002/9781118268667.ch5
Growth factor-mediated telomerase activity in ovarian cancer cells
Bermudez, Y. (2007) · Digital Commons - University of South Florida (University of South Florida)
The renal cell cancer methylome: tumor biology and clinical applications
van Vlodrop, I. J. H. (2012) · doi:10.26481/dis.20120323iv
The E2F1/DNMT1 axis represses AR in both normal and malignant prostate epithelium
Valdez, C. D. (2011) · Deep Blue (University of Michigan)
Elucidation of thioredoxin reductase 1 as an anticancer drug target
Stafford, W. C. (2015) · Figshare
Expression of shelterin and shelterin-associated genes in breast cancer cell lines
Motevalli, A. (2014) · Brunel University Research Archive (BURA) (Brunel University London)
Degerman, S. (2010) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Telomere Length, Methylation and Nutrition
Karami, F., & Mehdipour, P. (2012) · Springer eBooks · doi:10.1007/978-94-007-4632-9_6
TELOMERASE ACTIVATION AND ITS CLINICAL IMPLICATIONS IN HUMAN THYROID TUMORS
Wang, N. (2015) · Figshare
Stem cell characterisation: a guide to stem cell types, technologies, and future applications
Re, J. L., Shrestha, R., & Sciorra, L. J. (2015) · doi:10.1002/9781118846193.ch17
Review Article Epigenetics and Epigenetic Alterations in Pancreatic Cancer
Omura, N., & Goggins, M. (2015)
Signalling pathways in renal cell carcinoma with a focus on telomerase regulation
Sitaram, R. T. (2010)
Gordon, C.-A. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/xq4f-6v91
Haraguchi, K., Sato, S., Habu, M., Yada, N., Hayakawa, M., Sasaguri, M., Yoshioka, I., Tominaga, K., & Takenaka, S. (2023) · Electroanalysis · doi:10.1002/elan.202200564
Licchesi, J. D. F., Westra, W. H., Hooker, C. M., & Herman, J. G. (2023) · doi:10.1158/1078-0432.c.6517165.v1
Self-citationBasic Hematopoiesis and Leukemia Stem Cells
Hwang, W. Y. K., Bari, S., Ng, L. G., Itahana, K., Li, S., Koh, J. Y. P., & Than, H. (2023) · Springer eBooks · doi:10.1007/978-981-99-3810-0_1
Niknam, M., Naghibalhossaini, F., Zamani, M., Hosseini, S. V., & Mokarram, P. (2024) · PubMed Central · doi:10.22099/mbrc.2023.48009.1850
Omeostasi dei telomeri nelle sindromi mielodisplastiche
Berardinelli, E. (2014) · Università Politecnica delle Marche (Università Politecnica delle Marche)
Apolónio, J. D., Dias, J. S., Fernandes, M. T., Komosa, M., Lipman, T., Zhang, C. H., Leão, R., Lee, D. D., Nunes, N. M., Maia, A.-T., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22612792
Apolónio, J. D., Dias, J. S., Fernandes, M. T., Komosa, M., Lipman, T., Zhang, C. H., Leão, R., Lee, D., Nunes, N. M., Maia, A.-T., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22612795
Metadata
- Authors
- Zinn, R. L., Pruitt, K., Eguchi, S., Baylin, S. B., & Herman, J. G.
- Affiliations
- Johns Hopkins University (US)
- Venue
- Cancer Research
- Published
- 2007-01-01
- Volume
- 67
- Issue
- 1
- Pages
- 194-201
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2069698023
- Cited by
- 210
- References
- 28
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 5 · 2023: 11 · 2022: 9 · 2021: 6 · 2020: 13 · 2019: 15 · 2018: 11 · 2017: 9 · 2016: 16 · 2015: 15 · 2014: 11 · 2013: 9 · 2012: 12
- FWCI
- 6.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA088843, P50CA088843)
- National Institute of Environmental Health Sciences (R01ES011858, ES 11858)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- hTERT, telomerase reverse transcriptase, promoter methylation, transcription start sites, gene expression, cancer cell lines, CpG islands, histone modifications, H3K9 acetylation, H3K4 dimethylation, H3K9 trimethylation, H3K27me3, gene silencing, breast cancer, lung cancer, colon cancer
- MeSH terms
- Alleles, Breast Neoplasms, Chromatin, Colonic Neoplasms, Humans, Leukemia, Lung Neoplasms, Neoplasms, Promoter Regions, Genetic, Gene Expression, Caco-2 Cells, Telomerase, DNA Methylation, Transcription Initiation Site, HCT116 Cells, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review